These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 8247961

  • 1. Dystrophin analysis in the diagnosis of childhood muscular dystrophy: an immunohistochemical study of 75 cases.
    Jay V, Becker LE, Ackerley C, Ray P.
    Pediatr Pathol; 1993; 13(5):635-57. PubMed ID: 8247961
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunostaining of dystrophin and utrophin in skeletal muscle of dystrophinopathies.
    Sahashi K, Ibi T, Suoh H, Nakao N, Tashiro M, Marui K, Arahata K, Sugita H.
    Intern Med; 1994 May; 33(5):277-83. PubMed ID: 7949630
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Abnormal localization of laminin subunits in muscular dystrophies.
    Hayashi YK, Engvall E, Arikawa-Hirasawa E, Goto K, Koga R, Nonaka I, Sugita H, Arahata K.
    J Neurol Sci; 1993 Oct; 119(1):53-64. PubMed ID: 8246011
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dystrophin immunostaining of muscle from Chinese patients with various neuromuscular diseases.
    Jong YJ, Chuang YH, Chen SS, Chen BH, Chiang CH.
    J Formos Med Assoc; 1991 Dec; 90(12):1143-8. PubMed ID: 1686882
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical significance of dystrophin test for patients with various neuromuscular diseases--immunofluorescence and immunoblot analyses of dystrophin abnormalities].
    Ikeya K, Saito K, Yamauchi A, Kondo E, Komine S, Ikenaka H, Mishima M, Takahashi R, Harada T, Fukuyama Y.
    No To Hattatsu; 1993 Jul; 25(4):328-34. PubMed ID: 8338694
    [Abstract] [Full Text] [Related]

  • 13. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 3. Differential diagnosis and prognosis.
    Nicholson LV, Johnson MA, Bushby KM, Gardner-Medwin D, Curtis A, Ginjaar IB, den Dunnen JT, Welch JL, Butler TJ, Bakker E.
    J Med Genet; 1993 Sep; 30(9):745-51. PubMed ID: 8411069
    [Abstract] [Full Text] [Related]

  • 14. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.
    Arahata K, Beggs AH, Honda H, Ito S, Ishiura S, Tsukahara T, Ishiguro T, Eguchi C, Orimo S, Arikawa E.
    J Neurol Sci; 1991 Feb; 101(2):148-56. PubMed ID: 2033400
    [Abstract] [Full Text] [Related]

  • 15. Duchenne and Becker muscular dystrophy: contribution of a molecular and immunohistochemical analysis in diagnosis in Morocco.
    Bellayou H, Hamzi K, Rafai MA, Karkouri M, Slassi I, Azeddoug H, Nadifi S.
    J Biomed Biotechnol; 2009 Feb; 2009():325210. PubMed ID: 19461958
    [Abstract] [Full Text] [Related]

  • 16. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects.
    Mizuno Y, Nonaka I, Hirai S, Ozawa E.
    J Neurol Sci; 1993 Oct; 119(1):43-52. PubMed ID: 8246010
    [Abstract] [Full Text] [Related]

  • 17. A homologue of dystrophin is expressed at the blood vessel membrane of DMD and BMD patients: immunological evidence.
    Augier N, Boucraut J, Léger J, Anoal M, Nicholson LV, Voelkel MA, Léger JJ, Pellissier JF.
    J Neurol Sci; 1992 Feb; 107(2):233-8. PubMed ID: 1564523
    [Abstract] [Full Text] [Related]

  • 18. Dystrophin assay in muscular dystrophies: an Indian experience.
    Jain S, Sarkar C, Dinda AK, Maheshwari MC.
    Natl Med J India; 1993 Feb; 6(6):259-62. PubMed ID: 7950930
    [Abstract] [Full Text] [Related]

  • 19. Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin.
    Bulman DE, Murphy EG, Zubrzycka-Gaarn EE, Worton RG, Ray PN.
    Am J Hum Genet; 1991 Feb; 48(2):295-304. PubMed ID: 1990838
    [Abstract] [Full Text] [Related]

  • 20. Immunofluorescence dystrophin study in Duchenne dystrophy through the concomitant use of two antibodies directed against the carboxy-terminal and the amino-terminal region of the protein.
    Vainzof M, Zubrzycka-Gaarn EE, Rapaport D, Passos-Bueno MR, Pavanello RC, Pavanello-Filho I, Zatz M.
    J Neurol Sci; 1991 Feb; 101(2):141-7. PubMed ID: 1709683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.